Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials. [PDF]
Gooderham MJ +8 more
europepmc +1 more source
Salivary Melatonin Levels in Comparison with Disease Features and Antihistamine Use: Prospective Follow-Up of Atopic Dermatitis Patients. [PDF]
Tomašević R +5 more
europepmc +1 more source
Real-World Efficacy and Safety of Upadacitinib in Korean Patients With Atopic Dermatitis. [PDF]
Park SY +7 more
europepmc +1 more source
EP262, an MRGPRX2 Antagonist for the Treatment of Atopic Dermatitis: Results From the Phase 2 Randomized EASE Study. [PDF]
Dehn S +6 more
europepmc +1 more source
Real-World Evidence for the Impact of Minimal Disease Activity on Quality of Life in Atopic Dermatitis: An Interim Analysis of the Prospective, Multicenter, Non-Interventional UP-TAINED Study. [PDF]
Lauffer F +9 more
europepmc +1 more source
Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis. [PDF]
Weidinger S +9 more
europepmc +1 more source
Early Clinical Response Predicts Treatment Persistence in Advanced Therapy-naive Atopic Dermatitis. [PDF]
Martínez-Simón JJ +9 more
europepmc +1 more source
Clinical Significance of Malassezia-Specific IgE in Assessing the Severity of Head and Neck Involvement in Korean Atopic Dermatitis Patients. [PDF]
Kim HN +5 more
europepmc +1 more source
Cardiovascular Risk Factors in Adults with Atopic Dermatitis: A Cross-sectional Study. [PDF]
Sanabria-de la Torre R +4 more
europepmc +1 more source
Pilot Study Regarding Translation of Patient-Oriented Eczema Measure Questionnaire in Romanian Language in Assessing the Correlation Between Quality of Life and Disease Severity in Children with Atopic Dermatitis. [PDF]
Miulescu RG +8 more
europepmc +1 more source

